ResMed (NYSE:RMD) Cut to “Hold” at StockNews.com
StockNews.com downgraded shares of ResMed (NYSE:RMD – Free Report) from a buy rating to a hold rating in a research report report published on Wednesday morning. A number of other equities research analysts have also recently weighed in on RMD. KeyCorp lifted their price objective on shares of ResMed from $266.00 to $280.00 and gave […]
StockNews.com downgraded shares of ResMed (NYSE:RMD – Free Report) from a buy rating to a hold rating in a research report report published on Wednesday morning. A number of other equities research analysts have also recently weighed in on RMD. KeyCorp lifted their price objective on shares of ResMed from $266.00 to $280.00 and gave […]
